Related Experiment Video
Updated: Sep 15, 2025

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Serum trihalomethanes and cognitive decline: investigating environmental risk factors for neurodegenerative diseases
Jianping Liu1, Sufang Wang1, Yuanying Song1
1Department of Neurology, Yancheng Third People's Hospital (The Sixth Affiliated Hospital of Nantong University, The Yancheng School of Clinical Medicine of Nanjing Medical University, The Affiliated Hospital of Jiangsu Vocational College of Medicine), Yancheng, Jiangsu, China.
Backgrounds:
Trihalomethanes (THMs), byproducts of water chlorination, are pervasive in drinking water supplies and have known systemic toxicity. However, their potential neurotoxic effects, particularly on cognitive function, remain poorly understood. This study investigates the association between serum THM concentrations and cognitive decline, aiming to identify environmental risk factors for neurodegenerative diseases.
Methods:
Data were drawn from the National Health and Nutrition Examination Survey (NHANES) 2011-2014 cohort. A final analytic sample of 743 participants aged 60 years or older was analyzed. Serum concentrations of four THM species-chloroform, bromodichloromethane (BDCM), dibromochloromethane (DBCM), and bromoform (TBM)-were measured. Cognitive performance was assessed using CERAD Word Learning and Delayed Recall, animal fluency test (AFT), and digit symbol substitution test (DSST). Cognitive impairment was defined as scores below the 25th percentile. Multivariate logistic regression, restricted cubic splines (RCS), and subgroup interaction analyses were used to explore associations.
Results:
Higher serum THM concentrations were significantly associated with increased odds of cognitive impairment. In the fully adjusted model, individuals in the highest quartile of total THMs (TTHMs) had a 2.50-fold higher risk (95% CI: 1.68-3.71) compared to the lowest quartile. RCS analysis revealed a non-linear association between BDCM and cognitive decline, particularly in the AFT. Subgroup analysis indicated that older adults (≥70 years), females, and individuals with hypertension or diabetes were more susceptible to THM-related cognitive impairment.
Conclusion:
Elevated serum THM levels are independently associated with cognitive impairment, particularly in vulnerable populations. These findings suggest that THMs may act as environmental neurotoxicants contributing to cognitive decline. Public health efforts to reduce THM exposure could play a role in mitigating the risk of neurodegenerative diseases.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Alzheimer's Disease: Treatment
Cognitive Development During Adulthood

